Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging
Sponsor: Stanford University
Listed as NCT04981223, this NA trial focuses on Prostate Cancer and remains ongoing. Sponsored by Stanford University, it has been updated 10 times since 2022, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
10 versions recorded-
May 2025 — Present [monthly]
Active Not Recruiting NA
Status: Completed → Active Not Recruiting
-
Oct 2024 — May 2025 [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2024 — Oct 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Mar 2024 — May 2024 [monthly]
Recruiting NA
-
Aug 2023 — Mar 2024 [monthly]
Recruiting NA
-
Jul 2022 — Aug 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2022 — Jul 2022 [monthly]
Not Yet Recruiting NA
-
Sep 2021 — Feb 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .